TYP 0.00% 2.1¢ tryptamine therapeutics limited

So this might be a bit naive, but if the EX1 technology, no-how...

  1. 90 Posts.
    lightbulb Created with Sketch. 20
    So this might be a bit naive, but if the EX1 technology, no-how and uniqueness is worth so much (as we've been told) and with the share price in the mid-teens, why is EX1 not an M&A target? Or maybe it is (but we've not been told).
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $22.87M
Open High Low Value Volume
2.1¢ 2.1¢ 2.0¢ $38.86K 1.852M

Buyers (Bids)

No. Vol. Price($)
8 1254454 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 71325 1
View Market Depth
Last trade - 15.30pm 28/08/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.